1. Department of Surgical Oncology, the First Affiliated Hospital of Xiamen University and Xiamen Cancer Center, Xiamen 361003; 2. The First Clinical Medical College, Fujian Medical University, Fuzhou 350004, Fujian, China
[1] 段晓秋，王 晶，申维喜，等. 死亡受体Fas在TRAIL 联合三氧化二砷诱导人胃癌细胞凋亡中的作用[J]. 癌变·畸变·突变，2012，24(6)：422-426.[2] Matsuoka J，Yashiro M，Sakurai K，et al. Role of the stemness Factors Sox2，Oct3/4，and Nanog in gastric carcinoma[J]. J Surg Res，2012，174(1)：130-135.[3］ Livak KJ，Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-△△C t method[J]. Methods，2001，25(4)：402-408.[4] Ikushima H，Todo T，Ino Y，et al. Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors[J]. Cell Stem Cell， 2009，5(5)：504-514.[5] Colllgnon J，Sockanathan S，Hacher A，et al. A comparison of the properties of SOX3 with Sry and two related genes，SOX1 and SOX2[J]. Development，1996，122(2)：509-520.[6] Otsubo T，Akiyama Y，Yanagihara K，et al. SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis[J]. B J Cancer，2008，98( 4)：824-831. [7] Unterluggauer H，Hutter E，Voglauer R，et al. Identification of cultivation independent markers of human endothelial cell senescence in vitro[J]. Biogerontology，2007，8(4)：383-397.[8] Costa FF，Le Blanc AK，Brodin BB. Cancer/testis antigens， stem cells and cancer[J]. Stem Cells，2007，25(3)：707-711.[9] Mizoshita T，Tsukamoto T，Inada K，et al. Immunohistochemically detectable CDX2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types，with no correlation to non-neoplastic surrounding mucosa[J]. Pathol Int，2004， 54(6)：392-400. [10] Zhang X，Yu H，Yang Y，et al. SOX2 in gastric carcinoma， but not Hath1，is related to patients’clinicopathological features and prognosis[J]. J Gastrointest Surg，2010，14(8)： 1220-1226.
